Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 244

1.

Prediction of progression in idiopathic pulmonary fibrosis using CT scans at baseline: A quantum particle swarm optimization - Random forest approach.

Shi Y, Wong WK, Goldin JG, Brown MS, Kim GHJ.

Artif Intell Med. 2019 Sep;100:101709. doi: 10.1016/j.artmed.2019.101709. Epub 2019 Aug 28.

PMID:
31607341
2.

Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial.

Richeldi L, Fernández Pérez ER, Costabel U, Albera C, Lederer DJ, Flaherty KR, Ettinger N, Perez R, Scholand MB, Goldin J, Peony Yu KH, Neff T, Porter S, Zhong M, Gorina E, Kouchakji E, Raghu G.

Lancet Respir Med. 2019 Sep 27. pii: S2213-2600(19)30262-0. doi: 10.1016/S2213-2600(19)30262-0. [Epub ahead of print]

PMID:
31575509
3.

Intravenous stem cell dose and changes in quantitative lung fibrosis and DLCO in the AETHER trial: a pilot study.

Fishman JE, Kim GJ, Kyeong NY, Goldin JG, Glassberg MK.

Eur Rev Med Pharmacol Sci. 2019 Sep;23(17):7568-7572. doi: 10.26355/eurrev_201909_18877.

4.

Prediction of idiopathic pulmonary fibrosis progression using early quantitative changes on CT imaging for a short term of clinical 18-24-month follow-ups.

Kim GHJ, Weigt SS, Belperio JA, Brown MS, Shi Y, Lai JH, Goldin JG.

Eur Radiol. 2019 Aug 26. doi: 10.1007/s00330-019-06402-6. [Epub ahead of print]

PMID:
31451973
5.

Using transitional changes on HRCT to monitor the impact of cyclophosphamide or mycophenolate on systemic sclerosis-related interstitial lung disease.

Kim GHJ, Tashkin DP, Lo P, Brown MS, Volkmann ER, Gjertson DW, Khanna D, Elashoff RM, Tseng CH, Roth MD, Goldin JG.

Arthritis Rheumatol. 2019 Aug 20. doi: 10.1002/art.41085. [Epub ahead of print]

PMID:
31430058
6.

Pneumoproteins KL-6 and CCL-18 Predict Progression of Interstitial Lung Disease in Systemic Sclerosis.

Volkmann ER, Tashkin DP, Kuwana M, Li N, Roth MD, Charles J, Hant FN, Bogatkevich GS, Akter T, Kim G, Goldin J, Khanna D, Clements PJ, Furst DE, Elashoff RM, Silver RM, Assassi S.

Arthritis Rheumatol. 2019 Jun 24. doi: 10.1002/art.41020. [Epub ahead of print]

PMID:
31233287
7.

Components of Radiologic Progressive Disease Defined by RECIST 1.1 in Patients with Metastatic Clear Cell Renal Cell Carcinoma.

Coy HJ, Douek ML, Ruchalski K, Kim HJ, Gutierrez A, Patel M, Sai V, Margolis DJA, Kaplan A, Brown M, Goldin J, Raman SS.

Radiology. 2019 Jul;292(1):103-109. doi: 10.1148/radiol.2019182922. Epub 2019 May 14.

PMID:
31084479
8.

Cyclophosphamide for Systemic Sclerosis-related Interstitial Lung Disease: A Comparison of Scleroderma Lung Study I and II.

Volkmann ER, Tashkin DP, Sim M, Li N, Khanna D, Roth MD, Clements PJ, Hoffmann-Vold AM, Furst DE, Kim G, Goldin J, Elashoff RM.

J Rheumatol. 2019 Oct;46(10):1316-1325. doi: 10.3899/jrheum.180441. Epub 2019 Feb 15.

PMID:
30770517
9.

Sleep-disordered breathing among patients admitted for inpatient video-EEG monitoring.

Sivathamboo S, Farrand S, Chen Z, White EJ, Pattichis AA, Hollis C, Carino J, Roberts CJ, Minogue T, Jones NC, Yerra R, French C, Perucca P, Kwan P, Velakoulis D, O'Brien TJ, Goldin J.

Neurology. 2019 Jan 15;92(3):e194-e204. doi: 10.1212/WNL.0000000000006776. Epub 2018 Dec 14.

PMID:
30552299
10.

Longitudinal Changes in Quantitative Interstitial Lung Disease on Computed Tomography after Immunosuppression in the Scleroderma Lung Study II.

Goldin JG, Kim GHJ, Tseng CH, Volkmann E, Furst D, Clements P, Brown M, Roth M, Khanna D, Tashkin DP.

Ann Am Thorac Soc. 2018 Nov;15(11):1286-1295. doi: 10.1513/AnnalsATS.201802-079OC.

PMID:
30265153
11.

Fostering Strategies to Expand the Consumption of Edible Insects: The Value of a Tripartite Coalition between Academia, Industry, and Government.

Mason JB, Black R, Booth SL, Brentano A, Broadbent B, Connolly P, Finley J, Goldin J, Griffin T, Hagen K, Lesnik J, Lewis G, Pan Z, Ramos JM, Ranalli M, Rojas G, Shockley M, Stull VJ, Swietlik D.

Curr Dev Nutr. 2018 Jun 15;2(8):nzy056. doi: 10.1093/cdn/nzy056. eCollection 2018 Aug.

12.

Interpretation of HRCT Scans in the Diagnosis of IPF: Improving Communication Between Pulmonologists and Radiologists.

Chung JH, Goldin JG.

Lung. 2018 Oct;196(5):561-567. doi: 10.1007/s00408-018-0143-5. Epub 2018 Aug 10. Review.

13.

Integration of Chest CT CAD into the Clinical Workflow and Impact on Radiologist Efficiency.

Brown M, Browning P, Wahi-Anwar MW, Murphy M, Delgado J, Greenspan H, Abtin F, Ghahremani S, Yaghmai N, da Costa I, Becker M, Goldin J.

Acad Radiol. 2019 May;26(5):626-631. doi: 10.1016/j.acra.2018.07.006. Epub 2018 Aug 8.

PMID:
30097402
14.

Computed Tomographic Biomarkers in Idiopathic Pulmonary Fibrosis. The Future of Quantitative Analysis.

Wu X, Kim GH, Salisbury ML, Barber D, Bartholmai BJ, Brown KK, Conoscenti CS, De Backer J, Flaherty KR, Gruden JF, Hoffman EA, Humphries SM, Jacob J, Maher TM, Raghu G, Richeldi L, Ross BD, Schlenker-Herceg R, Sverzellati N, Wells AU, Martinez FJ, Lynch DA, Goldin J, Walsh SLF.

Am J Respir Crit Care Med. 2019 Jan 1;199(1):12-21. doi: 10.1164/rccm.201803-0444PP. No abstract available.

15.

Predicting Outcome in Idiopathic Pulmonary Fibrosis Using Automated Computed Tomography Analysis.

Goldin JG.

Am J Respir Crit Care Med. 2018 Sep 15;198(6):701-702. doi: 10.1164/rccm.201804-0657ED. No abstract available.

PMID:
29708398
16.

Building a high-resolution T2-weighted MR-based probabilistic model of tumor occurrence in the prostate.

Nagarajan MB, Raman SS, Lo P, Lin WC, Khoshnoodi P, Sayre JW, Ramakrishna B, Ahuja P, Huang J, Margolis DJA, Lu DSK, Reiter RE, Goldin JG, Brown MS, Enzmann DR.

Abdom Radiol (NY). 2018 Sep;43(9):2487-2496. doi: 10.1007/s00261-018-1495-2.

PMID:
29460041
17.

Sleep-disordered breathing in epilepsy: epidemiology, mechanisms, and treatment.

Sivathamboo S, Perucca P, Velakoulis D, Jones NC, Goldin J, Kwan P, O'Brien TJ.

Sleep. 2018 Apr 1;41(4). doi: 10.1093/sleep/zsy015. Review.

PMID:
29394413
18.

Quantitative bone scan lesion area as an early surrogate outcome measure indicative of overall survival in metastatic prostate cancer.

Brown MS, Kim GHJ, Chu GH, Ramakrishna B, Allen-Auerbach M, Fischer CP, Levine B, Gupta PK, Schiepers CW, Goldin JG.

J Med Imaging (Bellingham). 2018 Jan;5(1):011017. doi: 10.1117/1.JMI.5.1.011017. Epub 2018 Jan 11.

19.

Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.

Sullivan KM, Goldmuntz EA, Keyes-Elstein L, McSweeney PA, Pinckney A, Welch B, Mayes MD, Nash RA, Crofford LJ, Eggleston B, Castina S, Griffith LM, Goldstein JS, Wallace D, Craciunescu O, Khanna D, Folz RJ, Goldin J, St Clair EW, Seibold JR, Phillips K, Mineishi S, Simms RW, Ballen K, Wener MH, Georges GE, Heimfeld S, Hosing C, Forman S, Kafaja S, Silver RM, Griffing L, Storek J, LeClercq S, Brasington R, Csuka ME, Bredeson C, Keever-Taylor C, Domsic RT, Kahaleh MB, Medsger T, Furst DE; SCOT Study Investigators.

N Engl J Med. 2018 Jan 4;378(1):35-47.

20.

Models of care for non-invasive ventilation in the Acute COPD Comparison of three Tertiary hospitals (ACT3) study.

Parker K, Perikala V, Aminazad A, Deng Z, Borg B, Buchan C, Toghill J, Irving LB, Goldin J, Charlesworth D, Mahal A, Illesinghe S, Naughton MT, Young A.

Respirology. 2018 May;23(5):492-497. doi: 10.1111/resp.13228. Epub 2017 Dec 10.

PMID:
29224257
21.

Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper.

Lynch DA, Sverzellati N, Travis WD, Brown KK, Colby TV, Galvin JR, Goldin JG, Hansell DM, Inoue Y, Johkoh T, Nicholson AG, Knight SL, Raoof S, Richeldi L, Ryerson CJ, Ryu JH, Wells AU.

Lancet Respir Med. 2018 Feb;6(2):138-153. doi: 10.1016/S2213-2600(17)30433-2. Epub 2017 Nov 15. Review.

22.

Novel lung imaging biomarkers and skin gene expression subsetting in dasatinib treatment of systemic sclerosis-associated interstitial lung disease.

Martyanov V, Kim GJ, Hayes W, Du S, Ganguly BJ, Sy O, Lee SK, Bogatkevich GS, Schieven GL, Schiopu E, Marangoni RG, Goldin J, Whitfield ML, Varga J.

PLoS One. 2017 Nov 9;12(11):e0187580. doi: 10.1371/journal.pone.0187580. eCollection 2017.

23.

Reliability and minimal clinically important differences of forced vital capacity: Results from the Scleroderma Lung Studies (SLS-I and SLS-II).

Kafaja S, Clements PJ, Wilhalme H, Tseng CH, Furst DE, Kim GH, Goldin J, Volkmann ER, Roth MD, Tashkin DP, Khanna D.

Am J Respir Crit Care Med. 2018 Mar 1;197(5):644-652. doi: 10.1164/rccm.201709-1845OC. Epub 2017 Nov 3.

24.

Interstitial lung disease points to consider for clinical trials in systemic sclerosis.

Khanna D, Seibold J, Goldin J, Tashkin DP, Furst DE, Wells A.

Rheumatology (Oxford). 2017 Sep 1;56(suppl_5):v27-v32. doi: 10.1093/rheumatology/kex203. Review.

25.

Biology is king and continues to rule.

McLoughlin KC, Goldin JW, Ripley RT.

J Thorac Cardiovasc Surg. 2017 Oct;154(4):1448-1449. doi: 10.1016/j.jtcvs.2017.07.047. Epub 2017 Aug 4. No abstract available.

26.

A prospective cohort study of thoracic ultrasound in acute respiratory failure: the C3PO protocol.

Wallbridge PD, Joosten SA, Hannan LM, Steinfort DP, Irving L, Goldin J, Hew M.

JRSM Open. 2017 May 2;8(5):2054270417695055. doi: 10.1177/2054270417695055. eCollection 2017 May.

27.

Obstructive pulmonary disease in patients with previous tuberculosis: Pathophysiology of a community-based cohort.

Allwood BW, Gillespie R, Galperin-Aizenberg M, Bateman M, Olckers H, Taborda-Barata L, Calligaro GL, Said-Hartley Q, Van Zyl-Smit R, Cooper CB, Van Rikxoort E, Goldin J, Beyers N, Bateman ED.

S Afr Med J. 2017 Apr 25;107(5):440-445. doi: 10.7196/SAMJ.2017.v107i5.12118.

28.

Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis-Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II.

Volkmann ER, Tashkin DP, Li N, Roth MD, Khanna D, Hoffmann-Vold AM, Kim G, Goldin J, Clements PJ, Furst DE, Elashoff RM.

Arthritis Rheumatol. 2017 Jul;69(7):1451-1460. doi: 10.1002/art.40114. Epub 2017 May 23.

29.

The effect of radiation dose reduction on computer-aided detection (CAD) performance in a low-dose lung cancer screening population.

Young S, Lo P, Kim G, Brown M, Hoffman J, Hsu W, Wahi-Anwar W, Flores C, Lee G, Noo F, Goldin J, McNitt-Gray M.

Med Phys. 2017 Apr;44(4):1337-1346. doi: 10.1002/mp.12128. Epub 2017 Mar 14.

30.

TANGO - a screening tool to identify comorbidities on the causal pathway of nocturia.

Bower WF, Rose GE, Ervin CF, Goldin J, Whishaw DM, Khan F.

BJU Int. 2017 Jun;119(6):933-941. doi: 10.1111/bju.13774. Epub 2017 Feb 12.

31.

Safety and Immunogenicity of Adenovirus 35 Tuberculosis Vaccine Candidate in Adults with Active or Previous Tuberculosis. A Randomized Trial.

van Zyl-Smit RN, Esmail A, Bateman ME, Dawson R, Goldin J, van Rikxoort E, Douoguih M, Pau MG, Sadoff JC, McClain JB, Snowden MA, Benko J, Hokey DA, Rutkowski KT, Graves A, Shepherd B, Ishmukhamedov S, Kagina BMN, Abel B, Hanekom WA, Scriba TJ, Bateman ED.

Am J Respir Crit Care Med. 2017 May 1;195(9):1171-1180. doi: 10.1164/rccm.201603-0654OC.

PMID:
28060545
32.

Improved Cough and Cough-Specific Quality of Life in Patients Treated for Scleroderma-Related Interstitial Lung Disease: Results of Scleroderma Lung Study II.

Tashkin DP, Volkmann ER, Tseng CH, Roth MD, Khanna D, Furst DE, Clements PJ, Theodore A, Kafaja S, Kim GH, Goldin J, Ariolla E, Elashoff RM.

Chest. 2017 Apr;151(4):813-820. doi: 10.1016/j.chest.2016.11.052. Epub 2016 Dec 22.

33.

Evaluating small-airways disease in asthmatic patients: The utility of quantitative computed tomography.

Tashkin DP, Kim HJ, Zeidler M, Kleerup E, Goldin J.

J Allergy Clin Immunol. 2017 Jan;139(1):49-51.e2. doi: 10.1016/j.jaci.2016.11.010. Epub 2016 Nov 21. No abstract available.

PMID:
27884601
34.

SPIROMICS Protocol for Multicenter Quantitative Computed Tomography to Phenotype the Lungs.

Sieren JP, Newell JD Jr, Barr RG, Bleecker ER, Burnette N, Carretta EE, Couper D, Goldin J, Guo J, Han MK, Hansel NN, Kanner RE, Kazerooni EA, Martinez FJ, Rennard S, Woodruff PG, Hoffman EA; SPIROMICS Research Group.

Am J Respir Crit Care Med. 2016 Oct 1;194(7):794-806.

35.

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.

Tashkin DP, Roth MD, Clements PJ, Furst DE, Khanna D, Kleerup EC, Goldin J, Arriola E, Volkmann ER, Kafaja S, Silver R, Steen V, Strange C, Wise R, Wigley F, Mayes M, Riley DJ, Hussain S, Assassi S, Hsu VM, Patel B, Phillips K, Martinez F, Golden J, Connolly MK, Varga J, Dematte J, Hinchcliff ME, Fischer A, Swigris J, Meehan R, Theodore A, Simms R, Volkov S, Schraufnagel DE, Scholand MB, Frech T, Molitor JA, Highland K, Read CA, Fritzler MJ, Kim GHJ, Tseng CH, Elashoff RM; Sclerodema Lung Study II Investigators.

Lancet Respir Med. 2016 Sep;4(9):708-719. doi: 10.1016/S2213-2600(16)30152-7. Epub 2016 Jul 25.

36.

Sleep Disturbance, Obstructive Sleep Apnoea and Abnormal Periodic Leg Movements: Very Common Problems in Fabry Disease.

Talbot A, Hammerschlag G, Goldin J, Nicholls K.

JIMD Rep. 2017;31:37-44. doi: 10.1007/8904_2016_549. Epub 2016 Mar 24.

37.

FG-3019 anti-connective tissue growth factor monoclonal antibody: results of an open-label clinical trial in idiopathic pulmonary fibrosis.

Raghu G, Scholand MB, de Andrade J, Lancaster L, Mageto Y, Goldin J, Brown KK, Flaherty KR, Wencel M, Wanger J, Neff T, Valone F, Stauffer J, Porter S.

Eur Respir J. 2016 May;47(5):1481-91. doi: 10.1183/13993003.01030-2015. Epub 2016 Mar 10.

38.

A Novel Quantitative Computed Tomographic Analysis Suggests How Sirolimus Stabilizes Progressive Air Trapping in Lymphangioleiomyomatosis.

Argula RG, Kokosi M, Lo P, Kim HJ, Ravenel JG, Meyer C, Goldin J, Lee HS, Strange C, McCormack FX; MILES Study Investigators.

Ann Am Thorac Soc. 2016 Mar;13(3):342-9. doi: 10.1513/AnnalsATS.201509-631OC.

39.

Transitions to different patterns of interstitial lung disease in scleroderma with and without treatment.

Kim HJ, Tashkin DP, Gjertson DW, Brown MS, Kleerup E, Chong S, Belperio JA, Roth MD, Abtin F, Elashoff R, Tseng CH, Khanna D, Goldin JG.

Ann Rheum Dis. 2016 Jul;75(7):1367-71. doi: 10.1136/annrheumdis-2015-208929. Epub 2016 Jan 12.

PMID:
26757749
40.

Predictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis-associated interstitial lung disease trials.

Khanna D, Nagaraja V, Tseng CH, Abtin F, Suh R, Kim G, Wells A, Furst DE, Clements PJ, Roth MD, Tashkin DP, Goldin J.

Arthritis Res Ther. 2015 Dec 23;17:372. doi: 10.1186/s13075-015-0872-2.

41.

Assessment of previous tuberculosis status using questionnaires, chest X-rays and computed tomography scans.

Allwood BW, Goldin J, Said-Hartley Q, van Zyl-Smit RN, Calligaro G, Esmail A, Beyers N, Bateman ED.

Int J Tuberc Lung Dis. 2015 Dec;19(12):1435-40. doi: 10.5588/ijtld.14.0992.

PMID:
26614183
42.

A Randomized Pragmatic Clinical Trial of Chiropractic Care for Headaches With and Without a Self-Acupressure Pillow.

Vernon H, Borody C, Harris G, Muir B, Goldin J, Dinulos M.

J Manipulative Physiol Ther. 2015 Nov-Dec;38(9):637-643. doi: 10.1016/j.jmpt.2015.10.002. Epub 2015 Nov 6.

PMID:
26548737
43.

Robustness-Driven Feature Selection in Classification of Fibrotic Interstitial Lung Disease Patterns in Computed Tomography Using 3D Texture Features.

Chong DY, Kim HJ, Lo P, Young S, McNitt-Gray MF, Abtin F, Goldin JG, Brown MS.

IEEE Trans Med Imaging. 2016 Jan;35(1):144-57. doi: 10.1109/TMI.2015.2459064. Epub 2015 Jul 21.

PMID:
26208309
44.

Cyst-based measurements for assessing lymphangioleiomyomatosis in computed tomography.

Lo P, Brown MS, Kim H, Kim H, Argula R, Strange C, Goldin JG.

Med Phys. 2015 May;42(5):2287-95. doi: 10.1118/1.4916655.

PMID:
25979023
45.

CT staging and monitoring of fibrotic interstitial lung diseases in clinical practice and treatment trials: a position paper from the Fleischner Society.

Hansell DM, Goldin JG, King TE Jr, Lynch DA, Richeldi L, Wells AU.

Lancet Respir Med. 2015 Jun;3(6):483-96. doi: 10.1016/S2213-2600(15)00096-X. Epub 2015 May 11. Review.

PMID:
25975761
46.

Between-Scanner and Between-Visit Variation in Normal White Matter Apparent Diffusion Coefficient Values in the Setting of a Multi-Center Clinical Trial.

Huo J, Alger J, Kim H, Brown M, Okada K, Pope W, Goldin J.

Clin Neuroradiol. 2016 Dec;26(4):423-430. Epub 2015 Mar 20.

PMID:
25791203
47.

Relationship between quantitative radiographic assessments of interstitial lung disease and physiological and clinical features of systemic sclerosis.

Tashkin DP, Volkmann ER, Tseng CH, Kim HJ, Goldin J, Clements P, Furst D, Khanna D, Kleerup E, Roth MD, Elashoff R.

Ann Rheum Dis. 2016 Feb;75(2):374-81. doi: 10.1136/annrheumdis-2014-206076. Epub 2014 Dec 1.

PMID:
25452309
48.

Bone tumor segmentation on bone scans using context information and random forests.

Chu G, Lo P, Ramakrishna B, Kim H, Morris D, Goldin J, Brown M.

Med Image Comput Comput Assist Interv. 2014;17(Pt 1):601-8.

PMID:
25333168
49.

Comparison of the quantitative CT imaging biomarkers of idiopathic pulmonary fibrosis at baseline and early change with an interval of 7 months.

Kim HJ, Brown MS, Chong D, Gjertson DW, Lu P, Kim HJ, Coy H, Goldin JG.

Acad Radiol. 2015 Jan;22(1):70-80. doi: 10.1016/j.acra.2014.08.004. Epub 2014 Sep 26.

PMID:
25262954
50.

Toward clinically usable CAD for lung cancer screening with computed tomography.

Brown MS, Lo P, Goldin JG, Barnoy E, Kim GH, McNitt-Gray MF, Aberle DR.

Eur Radiol. 2014 Nov;24(11):2719-28. doi: 10.1007/s00330-014-3329-0. Epub 2014 Jul 24.

PMID:
25052078

Supplemental Content

Loading ...
Support Center